Ser-Ap-Es (Hydralazine Hydrochloride / Hydrochlorothiazide / Reserpine) - Summary

SER-AP-ES SUMMARY

Ser-Ap-Es^®

Ser-Ap-Es is an antihypertensive-diuretic combination, available as tablets for oral administration. Each tablet contains Serpasil (reserpine USP), 0.1 mg; Apresoline (hydralazine hydrochloride USP), 25 mg; and Esidrix (hydrochlorothiazide USP), 15 mg.

Ser-Ap-Es (hydralazine/hydrochlorothiazide/reserpine) is indicated for the following:

Hypertension (see boxed WARNING).

SER-AP-ES NEWS HIGHLIGHTS

Media Articles Related to Ser-Ap-Es (Hydralazine / Hydrochlorothiazide / Reserpine)

Pseudotumor Cerebri (Idiopathic Intracranial Hypertension)
Source: MedicineNet Brain Tumor Specialty [2008.09.30]

Study Finds Antioxidant Deficiency Linked To Pulmonary Hypertension
Source: Hypertension News From Medical News Today [2008.09.24]

Vitamin C Might Help Lower Hypertension
Source: MedicineNet High Blood Pressure Specialty [2008.09.22]

Using Honeybee Venom Toxin To Develop A New Tool For Studying Hypertension
Source: Hypertension News From Medical News Today [2008.09.19]

After Stroke, TPA Therapy OK Even For Those With Hypertension
Source: Hypertension News From Medical News Today [2008.09.09]

more>>